Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INTERACT MESO intraperitoneal paclitaxel study in primary malignant peritoneal mesothelioma
NL-OMON59255Phase 1Completed
- Sponsor
- Erasmus MC
- Start
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of paclitaxel in peritoneal mesothelioma, sponsored by Erasmus MC. Primary endpoint: Primary endpoint(s). Started Oct 2021; status: completed.
02
Drugs
paclitaxel
03
Conditions
peritoneal mesothelioma
Beyond the preview
Go deeper on NL-OMON59255.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON59255.